COMMUNIQUÉS West-GlobeNewswire

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
11/08/2026
– PDUFA target date of December 22, 2026 for lorundrostat; commercial preparations on-track for launch upon approval – – Appoints accomplished cardiovascular medicine executive Dr. Terry Ferguson as Chief Medical [...]
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
11/08/2026
ROCKVILLE, MD, Aug. 11, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, [...]
BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
11/08/2026
Continued to advance monotherapy and combination cohorts for all clinical programs Initiated dosing of BBO-11818 in combination with cetuximab and after the end of the quarter, initiated dosing of BBO-11818 in [...]
Mobia Medical Reports Second Quarter 2026 Financial Results
11/08/2026
AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today reported [...]
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
11/08/2026
NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at [...]
Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
11/08/2026
REDWOOD CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for [...]
SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
11/08/2026
- Final Analysis of Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia to be Conducted Following the 80 th Event - - 28 Patients Enrolled in Phase 2 Trial of SLS009 in Newly Diagnosed First-Line AML; [...]
Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results
11/08/2026
FDA grants RMAT designation for miv-cel in non-active secondary progressive multiple sclerosis (naSPMS) based on compelling clinical data, further expanding the therapy’s potential across neuroimmunology On track to [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/08/2026
PALO ALTO, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today [...]
Erasca Reports Second Quarter 2026 Business Updates and Financial Results
11/08/2026
Updated ERAS-0015 data in U.S. trial highlighted compelling monotherapy efficacy in 2L+ KRAS G12X PDAC and continued favorable tolerability, as well as further advancement of panitumumab CRC combination ERAS-0015 [...]
Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity
11/08/2026
WILMINGTON, Del., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001, a novel once-daily oral anti- [...]
Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1
11/08/2026
Prescription Drug User Fee Act target action date is February 12, 2027 If approved, tinlarebant would be the first-ever approved treatment for Stargardt Disease Type 1 SAN DIEGO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Belite [...]
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
11/08/2026
Robotic catheter revenue surpasses $1M in the quarter, growing 270% sequentially First GenesisX robotic system purchase by US hospital to be installed this fall Multiple Synchrony digital operating room systems sold and [...]
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
11/08/2026
Successfully completed human factors validation study and pharmacokinetic study for Anaphylm™ (dibutepinephrine) sublingual film Remains on track to resubmit Anaphylm NDA to the FDA in Q3 2026 Continues pre-launch [...]
Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
11/08/2026
Enrollment in Phase 2 HORIZON trial of MZE829 on track; data from all cohorts expected in late 2026 or early 2027 Phase 2 CIPheR trial of MZE782 in PKU initiated and enrollment ongoing; topline data expected in 2027 [...]
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
11/08/2026
Completed dosing in the REVEAL pivotal (N=17) and ASPIRE (N=4) trials evaluating TSHA-102 for Rett syndrome; expect to report topline data from 6 ‑ month interim analysis and FDA feedback on the BLA submission pathway [...]
ASHA Names 2026 Media Champion Award Recipients
11/08/2026
Rockville, MD, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The American Speech-Language-Hearing Association (ASHA) announced the recipients of ASHA’s 2026 Media Champion Awards today. These awards recognize media outlets, ASHA [...]
Rampart Withdraws Appeal of USPTO’s Invalidation Decision
11/08/2026
ST. PAUL, Minn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Egg Medical announced today that Rampart IC, LLC (“Rampart”) withdrew its appeal of the USPTO’s reexamination decision that the claims of Rampart’s U.S. Patent No. 11, [...]
Five Years of Unprecedented Growth: TimelyCare Redefines Student Well-Being
11/08/2026
Latest Inc. 5000 ranking cements TimelyCare’s position as a trusted, high-impact partner for educational communities. Fort Worth, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- TimelyCare, education’s most trusted virtual care [...]

Pages